(Q58045758)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239669%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

Gut microbiota: a potential new territory for drug targeting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239669%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239669%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jeremy K. Nicholson

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239669%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Houkai Li

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239669%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Liping Zhao

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239669%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239669%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Drug Discovery

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239669%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239669%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239669%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

123-129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239669%20AND%20SRC:MED&resulttype=core&format=json

Mutagenicity of dimethylated metabolites of inorganic arsenics.

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

The challenges of modeling mammalian biocomplexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Metagenomic analysis of the human distal gut microbiome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Metagenomics: genomic analysis of microbial communities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

An obesity-associated gut microbiome with increased capacity for energy harvest

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Microbial ecology: human gut microbes associated with obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

The fundamental basis of inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Gut flora in health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

The gut flora as a forgotten organ

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Toxicity classification from metabonomic data using a density superposition approach: ‘CLOUDS’

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

The gut microbiota as an environmental factor that regulates fat storage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Gut microorganisms, mammalian metabolism and personalized health care

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Antibiotic use, childhood affluence and irritable bowel syndrome (IBS)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Long-term ecological impacts of antibiotic administration on the human intestinal microbiota

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

The infection connection. Helicobacter pylori is more than just the cause of gastric ulcers--it offers an unprecedented opportunity to study changes in human microecology and the nature of chronic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

A Genomic View of the Human-Bacteroides thetaiotaomicron Symbiosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Genomic and metabolic adaptations of Methanobrevibacter smithii to the human gut

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Conserved features of type III secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Antidiabetic Effects of an Oral Administration of Lactobacillus casei in a Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Model using KK-Ay Mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Prevention of onset in an insulin‐dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Probiotics and prebiotics: role in clinical disease states

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Natural products from plant-associated microorganisms: distribution, structural diversity, bioactivity, and implications of their occurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Biomedicinals from the phytosymbionts of marine invertebrates: a molecular approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Application of ethyl chloroformate derivatization for gas chromatography-mass spectrometry based metabonomic profiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Simultaneous determination of 17 ginsenosides in rat urine by ultra performance liquid chromatography-mass spectrometry with solid-phase extraction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Pharmaco-metabonomic phenotyping and personalized drug treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Effect of intestinal microflora on the urinary metabolic profile of rats: a (1)H-nuclear magnetic resonance spectroscopy study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Metagenomics: application of genomics to uncultured microorganisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Diversity of the human intestinal microbial flora

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Persistence of DNA studied in different ex vivo and in vivo rat models simulating the human gut situation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Inter-species transplantation of gut microbiota from human to pigs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Helicobacter pylori eradication and gastric ulcer healing — comparison of three pantoprazole‐based triple therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Bacteria in the pathogenesis of inflammatory bowel disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 1: eradication of Helicobacter in the cachexia of idiopathic parkinsonism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, do

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 3: predicted probability and gradients of severity of idiopathic parkinsonism based on H. pylori antibody prof

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD2505

31 March 2020

Identifiers

DOI

10.1038/NRD2505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18239669%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 January 2020

1026288483

0 references

1 reference